Literature DB >> 24656634

The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.

Kazumitsu Sugiura1.   

Abstract

Generalized pustular psoriasis (GPP) is often present in patients with existing or prior psoriasis vulgaris (PV; "GPP with PV"). However, cases of GPP have been known to arise without a history of PV ("GPP alone"). There has long been debate over whether GPP alone and GPP with PV are distinct subtypes that are etiologically different from each other. We recently reported that the majority of GPP alone cases is caused by recessive mutations of IL36RN. In contrast, only a few exceptional cases of GPP with PV were found to have recessive IL36RN mutations. Very recently, we also reported that CARD14 p.Asp176His, a gain-of-function variant, is a predisposing factor for GPP with PV; in contrast, the variant is not associated with GPP alone in the Japanese population. These results suggest that GPP alone is genetically different from GPP with PV. IL36RN mutations are also found in some patients with severe acute generalized exanthematous pustulosis, palmar-plantar pustulosis, and acrodermatitis continua of hallopeau. CARD14 mutations and variants are causal or disease susceptibility factors of PV, GPP, or pityriasis rubra pilaris, depending on the mutation or variant position of CARD14. It is clinically important to analyze IL36RN mutations in patients with sterile pustulosis. For example, identifying recessive IL36RN mutations leads to early diagnosis of GPP, even at the first episode of pustulosis. In addition, individuals with IL36RN mutations are very susceptible to GPP or GPP-related generalized pustulosis induced by drugs (e.g., amoxicillin), infections, pregnancy, or menstruation.
Copyright © 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acrodermatitis continua of hallopeau; Acute generalized exanthematous pustulosis; CARD family; CARD14; DITRA; Generalized pustular psoriasis; IL36RN; Pityriasis rubra pilaris; Psoriasis vulgaris: Palmar-plantar pustulosis

Mesh:

Substances:

Year:  2014        PMID: 24656634     DOI: 10.1016/j.jdermsci.2014.02.006

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  21 in total

Review 1.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.

Authors:  Qian Zhang; Michael J Lenardo; David Baltimore
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

Review 2.  Use of granulocyte and monocyte adsorption apheresis in dermatology (Review).

Authors:  Laura Gnesotto; Guido Mioso; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2022-06-24       Impact factor: 2.751

Review 3.  Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era.

Authors:  Dennis McGonagle; Kay-Geert A Hermann; Ai Lyn Tan
Journal:  Rheumatology (Oxford)       Date:  2014-09-16       Impact factor: 7.580

Review 4.  The Immunogenetics of Psoriasis and Implications for Drug Repositioning.

Authors:  Xuan Xu; Hong-Yu Zhang
Journal:  Int J Mol Sci       Date:  2017-12-08       Impact factor: 5.923

Review 5.  Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations.

Authors:  Davide Martorana; Francesco Bonatti; Paola Mozzoni; Augusto Vaglio; Antonio Percesepe
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

6.  Microscopic Examination of Nail Clippings from Patients with Palmoplantar Pustulosis.

Authors:  Anber Ancel Tanaka; Betina Werner; Cassia Farris; Cassio Tornesy
Journal:  Dermatopathology (Basel)       Date:  2019-10-29

7.  Generalized pustular psoriasis induced by systemic steroid dose reduction.

Authors:  Danielle Cristine Westphal; Antonio Pedro Mendes Schettini; Petra Pereira de Souza; Jessica Castiel; Carlos Alberto Chirano; Mônica Santos
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

8.  Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies.

Authors:  Rajkumar Ganesan; Ernest L Raymond; Detlev Mennerich; Joseph R Woska; Gary Caviness; Christine Grimaldi; Jennifer Ahlberg; Rocio Perez; Simon Roberts; Danlin Yang; Kavita Jerath; Kristopher Truncali; Lee Frego; Eliud Sepulveda; Priyanka Gupta; Su-Ellen Brown; Michael D Howell; Keith A Canada; Rachel Kroe-Barrett; Jay S Fine; Sanjaya Singh; M Lamine Mbow
Journal:  MAbs       Date:  2017-07-20       Impact factor: 5.857

9.  Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease.

Authors:  Gabriela Fonseca-Camarillo; Janette Furuzawa-Carballeda; Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar; Rafael Barreto-Zuñiga; Braulio Martínez-Benitez; Montserrat A Lara-Velazquez
Journal:  J Inflamm (Lond)       Date:  2018-07-11       Impact factor: 4.981

10.  Genetic polymorphism of IL36RN in Han patients with generalized pustular psoriasis in Sichuan region of China: A case-control study.

Authors:  Zhongtao Li; Qianyi Yang; Sheng Wang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.